NCT06398730
A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 2, 2024
Completion: Jan 31, 2026